Barre syndrome is definitely one of the less common. This condition, which affects the body's nerves and causes muscle weakness that develops into paralysis, is serious. But, it can be treated.

Two AS01-adjuvanted vaccines for different pathogens -- the respiratory syncytial virus (RSV) vaccine (Arexvy) and the recombinant shingles vaccine (Shingrix) -- were tied to a lower dementia risk ...

This new Shingrix vaccine presentation eliminates the need for reconstitution, simplifying the administration process for ...

GSK plc (LSE/NYSE: GSK) today announced that the US Food and Drug Administration (FDA) has approved a prefilled syringe presentation of SHINGRIX (Zoster Vaccine Recombinant, Adjuvanted) for the ...

The UK’s drugs regulator has advised healthcare professionals to alert RSV vaccine recipients to Guillain-Barré syndrome symptoms, although the risk remains low.

British regulators issued the alert for two versions of a jab given to millions of pensioners and pregnant women after reports of patients developing a rare neurological disorder.

New data hint at a role for the AS01 adjuvant in vaccines for herpes zoster and respiratory syncytial virus in protecting against dementia.

The Department of Health and Human Services under Robert F. Kennedy Jr. has taken unprecedented steps to change how vaccines are evaluated, approved and recommended.

The Trump administration’s new vaccine advisers on Thursday endorsed this fall’s flu vaccinations for just about every American but threw in a twist: Only use certain shots free of an ...

Two doses of the vaccine are more than 90% effective at preventing shingles, and new data suggest that there is an additional benefit in protecting people against heart attacks, strokes and dementia.